The working principle of IHC markers involves the use of antibodies that specifically bind to the antigen (protein) of interest. These antibodies are conjugated to enzymes or fluorophores. When the antibody binds to its target antigen in the tissue, it can be visualized using a substrate that produces a colorimetric or fluorescent signal. This allows pathologists and researchers to identify and locate specific proteins within the tissue context.
